High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis.
Open Access
- 1 June 1995
- Vol. 36 (6) , 918-921
- https://doi.org/10.1136/gut.36.6.918
Abstract
Patients with familial adenomatous polyposis (FAP) develop periampullary duodenal tumours, suggesting that bile contributes to their formation. The hypothesis that bile contains carcinogens has been tested by looking for DNA adducts (markers of carcinogen exposure) in the duodenum of patients with or without FAP and by determining whether bile can produce DNA adducts in vitro. Using 32P-postlabelling to detect adducts, there was an excess (compared with unaffected patients) of DNA adducts in the duodenum of FAP patients and an excess of DNA adducts in the small bowel of rats treated with FAP bile, while bile from FAP patients formed significantly more DNA adducts in vitro than did bile from controls. In this study it is shown that the excess of adduct labelling produced by FAP bile in vitro depends on the pH of the incubate. While adduct labelling at pH 6-8 did not differ significantly between bile from six FAP patients and six controls, at pH 4-5 FAP bile, but not control bile, produced a near threefold excess of adduct labelling over that at pH 6-8. Therapy that increases duodenal pH may therefore alleviate duodenal polyposis.Keywords
This publication has 11 references indexed in Scilit:
- Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee).Journal of Clinical Pathology, 1994
- Bile acids do not form adducts when incubated with DNA in vitroCarcinogenesis: Integrative Cancer Research, 1994
- Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: Experience of two European centresBritish Journal of Surgery, 1993
- DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controlsCarcinogenesis: Integrative Cancer Research, 1993
- DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controlsCarcinogenesis: Integrative Cancer Research, 1992
- DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controlsCarcinogenesis: Integrative Cancer Research, 1991
- UPPER GASTROINTESTINAL CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSISThe Lancet, 1989
- Post-radiolabelling for detecting DNA damageMutagenesis, 1987
- Nuclease P1-mediated enhancement of sensitivity of 32P-Postlabeling test for structurally diverse DNA adductsCarcinogenesis: Integrative Cancer Research, 1986
- Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo.Proceedings of the National Academy of Sciences, 1984